Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Alterations of the gut microbiota and mucosal barrier are linked with metabolic diseases. Our aim was to investigate the potential benefit of the potential probiotic Bifidobacterium animalis ssp. lactis 420 in reducing high-fat diet-induced body weight gain and diabetes in mice. In the obesity model, C57Bl/6J mice were fed a high-fat diet (60 energy %) for 12 weeks, and gavaged daily with B. lactis 420 (10 9 cfu) or vehicle. In the diabetes model, mice were fed a high-fat, ketogenic diet (72 energy % fat) for 4 weeks, with a 6-week subsequent treatment with B. lactis 420 (10 8-10 10 cfu/day) or vehicle, after which they were analysed for body composition. We also analysed glucose tolerance, plasma lipopolysaccharide and target tissue inflammation using only one of the B. lactis 420 groups (109 cfu/day). Intestinal bacterial translocation and adhesion were analysed in a separate experiment using an Escherichia coli gavage. Body fat mass was increased in both obese (10.7±0.8 g (mean ± standard error of mean) vs. 1.86±0.21 g, P<0.001) and diabetic mice (3.01±0.4 g vs. 1.14±0.15 g, P<0.001) compared to healthy controls. Treatment with B. lactis 420 significantly decreased fat mass in obese (7.83 ± 0.67 g, P=0.007 compared to obese with vehicle) and diabetic mice (1.89 ± 0.16 g, P=0.02 for highest dose). This was reflected as reduced weight gain and improved glucose tolerance. Furthermore, B. lactis 420 decreased plasma lipopolysaccharide levels (P<0.001), liver inflammation (P=0.04), and E. coli adhesion in the distal gut (P<0.05). In conclusion, B. lactis 420 reduces fat mass and glucose intolerance in both obese and diabetic mice. Reduced intestinal mucosal adherence and plasma lipopolysaccharide suggest a mechanism related to reduced translocation of gut microbes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Many of these are suspected to stem from chronic low-grade inflammation, which has become a well-recognised risk factor for metabolic disease (Hotamisligil, 2006).”
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819 · cited 15×
“As germ-free mice are resistant to obesity caused by a HFD (Backhed et al. , 2007; Rabot et al. , 2010), the gut microbiota and gut-derived endotoxins have been proposed to participate in the development of diet-induced obesity in mice.”
InfluentialSelf-citationMechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615 · cited 13×
“Interestingly, it was shown that the conventionalisation of germ free mice modulated muscle AMPK activity demonstrating a role of the microbiota on this master regulator of energy metabolism (Backhed et al. , 2007).”
Influentialde La Serre, C. B., Ellis, C. L., Lee, J., Hartman, A. L., Rutledge, J. C., & Raybould, H. E. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00098.2010 · Cited by 949 · cited 2×
“…hypotheses include chylomicron-facilitated LPS-transport (Ghoshal et al. , 2009), decreased mucosal clearance of LPS by alkaline phosphatase (De la Serre et al. , 2010), and gut barrier disruption by various mechanisms related to the gut microbiota, such as an overly active gut endocannabinoid…”
Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion
Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., & Rane, S. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452516 · Cited by 709 · cited 2×
“…, 2013; Park et al. , 2013; Sato et al. , 2008), bifidobacteria (Cano et al. , 2013; Chen et al. , 2011; Kondo et al. , 2010) and their combination (Yadav et al. , 2013) to reduce body weight or fat mass in rodents and humans, the present study is the first to show an effect for a B. lactis strain…”
Kadooka, Y., Sato, M., Imaizumi, K., Ogawa, A., Ikuyama, K., Akai, Y., Okano, M., Kagoshima, M., & Tsuchida, T. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.19 · Cited by 700
The endocannabinoid system links gut microbiota to adipogenesis
Muccioli, G. G., Naslain, D., Bäckhed, F., Reigstad, C. S., Lambert, D. M., Delzenne, N. M., & Cani, P. D. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.46 · Cited by 691 · cited 1×
“…clearance of LPS by alkaline phosphatase (De la Serre et al. , 2010), and gut barrier disruption by various mechanisms related to the gut microbiota, such as an overly active gut endocannabinoid system (Muccioli et al. , 2010), or altered luminal bile acid profile (Stenman et al. , 2012, 2013).”
Chylomicrons promote intestinal absorption of lipopolysaccharides
Ghoshal, S., Witta, J., Zhong, J., de Villiers, W., & Eckhardt, E. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800156-jlr200 · Cited by 662 · cited 3×
“Luminal LPS may translocate through the gut epithelium via at least two different routes: the paracellular route through the tight-junctions, or transcellularly through enterocytes and engaged with chylomicron synthesis (Ghoshal et al. , 2009).”
InfluentialRabot, S., Membrez, M., Bruneau, A., Gérard, P., Harach, T., Moser, M., Raymond, F., Mansourian, R., & Chou, C. J. (2010) · The FASEB Journal · doi:10.1096/fj.10.164921 · Cited by 610 · cited 13×
“As germ-free mice are resistant to obesity caused by a HFD (Backhed et al. , 2007; Rabot et al. , 2010), the gut microbiota and gut-derived endotoxins have been proposed to participate in the development of diet-induced obesity in mice.”
InfluentialPark, D.-Y., Ahn, Y.-T., Park, S.-H., Huh, C.-S., Yoo, S.-R., Yu, R., Sung, M.-K., McGregor, R. A., & Choi, M.-S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059470 · Cited by 317 · cited 1×
“While some previous reports have shown various lactobacilli (Kim et al. , 2013; Park et al. , 2013; Sato et al. , 2008), bifidobacteria (Cano et al. , 2013; Chen et al. , 2011; Kondo et al. , 2010) and their combination (Yadav et al. , 2013) to reduce body weight or fat mass in rodents and humans,…”
Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus
Collado, M. C., Meriluoto, J., & Salminen, S. (2007) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2007.02212.x · Cited by 303 · cited 1×
“In previous studies, B420 prevented mucosal pathogen adhesion and improved tight-junction integrity in vitro (Collado et al. , 2007; Putaala et al. , 2008).”
NOD1 activators link innate immunity to insulin resistance
Schertzer, J. D., Tamrakar, A. K., Magalhães, J. G., Pereira, S., Bilan, P. J., Fullerton, M. D., Liu, Z., Steinberg, G. R., Giacca, A., Philpott, D. J., et al. (2011) · Diabetes · doi:10.2337/db11-0004 · Cited by 253
Stenman, L. K., Holma, R., Eggert, A., & Korpela, R. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00267.2012 · Cited by 222
Self-citationHigh-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids
Stenman, L. K. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i9.923 · Cited by 201
Self-citation
Cited by
Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk
Murphy, E. A., Velazquez, K. T., & Herbert, K. M. (2015) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000209 · Cited by 492
The Intestinal Microbiota in Metabolic Disease
Woting, A., & Blaut, M. (2016) · Nutrients · doi:10.3390/nu8040202 · Cited by 284
“breve B-3) alleviated diet-induced obesity [115,116].”
Scorletti, E., Afolabi, P. R., Miles, E. A., Smith, D. E., Almehmadi, A., Alshathry, A., Childs, C. E., Del Fabbro, S., Bilson, J., Moyses, H. E., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.031 · Cited by 237
Weitkunat, K., Stuhlmann, C., Postel, A., Rumberger, S., Fankhänel, M., Woting, A., Petzke, K. J., Gohlke, S., Schulz, T. J., Blaut, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06447-x · Cited by 207
Gut microbiota and immune crosstalk in metabolic disease
Burcelin, R. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.016 · Cited by 191
“Some probiotics can regulate metabolic disease [83] and have been involved in the control of bacterial translocation [18] and mucosal defense [75,84,85] through mechanisms not yet demonstrated.”
BackgroundSelf-citation
Metadata
- Authors
- Stenman, L. K., Waget, A., Garret, C., Klopp, P., Burcelin, R., & Lahtinen, S.
- Venue
- Beneficial Microbes
- Publisher
- Walter de Gruyter GmbH
- Published
- 2014-12-01
- Volume
- 5
- Issue
- 4
- Pages
- 437-446
- ISSN
- 1876-2883 (ISSN-L)
- 1876-2891
- OpenAlex
- W2135139633
- Cited by
- 147
- References
- 14
- FWCI
- 19.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.